title: Development of multiple basal cell carcinomas in mycosis fungoides treated with oral bexarotene.
authors.forename: Piergiacomo
authors.initials: P
authors.lastname: Calzavara-Pinton
authors.forename: Carla
authors.initials: C
authors.lastname: Leali
authors.forename: Marina
authors.initials: M
authors.lastname: Venturini
authors.forename: Raffaella
authors.initials: R
authors.lastname: Sala
authors.forename: Cristina
authors.initials: C
authors.lastname: Zane
mesh_terms: D000284:Administration, Oral; D016588:Anticarcinogenic Agents / Q000008:administration & dosage*; D000077610:Bexarotene; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*
chemical_list: D016588:Anticarcinogenic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene